Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
2.
Hypertens Res ; 35(1): 82-7, 2012 Jan.
Article in English | MEDLINE | ID: mdl-21956728

ABSTRACT

We investigated the influence of angiotensin-converting enzyme inhibitor (ACEi) treatment and physical exercise on arterial pressure (AP) and heart rate variability (HRV) in volunteer patients with hypertension. A total of 54 sedentary volunteers were divided into three groups: normotensive (NT Group), hypertensive (HT Group) and HT volunteers treated with ACEi (ACEi Group). All volunteers underwent an aerobic physical-training protocol for 15 weeks. HRV was investigated using a spectral analysis of a time series of R-R interval (RRi) that was obtained in a supine position and during a tilt test. Physical training promoted a significant reduction in the mean arterial pressure of the HT group (113±3 vs. 106±1 mm Hg) and the ACEi group (104±2 vs. 98±2 mm Hg). Spectral analysis of RRi in the supine position before physical training demonstrated that the NT and ACEi groups had similar values at low frequency (LF; 0.04-0.15 Hz) and high frequency (HF; 0.15-0.5 Hz) oscillations. The HT group had an increase in LF oscillations in absolute and normalized units and a decrease in HF oscillations in normalized units compared with the other groups. The HT group had the lowest responses to the tilt test during LF oscillations in normalized units. Physical training improved the autonomic modulation of the heart rate in the supine position only in the HT group. Physical training promoted a similar increase in autonomic modulation responses in the tilt test in all groups. Our findings show that aerobic physical training improves cardiac autonomic modulation in HT volunteers independently of ACEi treatment.


Subject(s)
Autonomic Nervous System/physiopathology , Blood Pressure/physiology , Exercise/physiology , Heart Rate/physiology , Hypertension/physiopathology , Adult , Angiotensin-Converting Enzyme Inhibitors/pharmacology , Angiotensin-Converting Enzyme Inhibitors/therapeutic use , Autonomic Nervous System/drug effects , Blood Pressure/drug effects , Enalapril/pharmacology , Enalapril/therapeutic use , Female , Heart Rate/drug effects , Humans , Hypertension/drug therapy , Male , Middle Aged , Sedentary Behavior , Tilt-Table Test
3.
Biopharm Drug Dispos ; 29(5): 280-8, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18551504

ABSTRACT

An enantioselective high-performance liquid chromatographic method for the analysis of carvedilol in plasma and urine was developed and validated using (-)-menthyl chloroformate (MCF) as a derivatizing reagent. Chloroform was used for extraction, and analysis was performed by HPLC on a C18 column with a fluorescence detector. The quantitation limit was 0.25 ng/ml for S(-)-carvedilol in plasma and 0.5 ng/ml for R(+)-carvedilol in plasma and for both enantiomers in urine. The method was applied to the study of enantioselectivity in the pharmacokinetics of carvedilol administered in a multiple dose regimen (25 mg/12 h) to a hypertensive elderly female patient. The data obtained demonstrated highest plasma levels for the R(+)-carvedilol (AUC(SS) (0-12) 75.64 vs 37.29 ng/ml). The enantiomeric ratio R(+)/S(-) was 2.03 for plasma and 1.49 for urine (Ae(0-12) 17.4 vs 11.7 microg).


Subject(s)
Adrenergic Antagonists/blood , Antihypertensive Agents/blood , Carbazoles/blood , Propanolamines/blood , Adrenergic Antagonists/chemistry , Adrenergic Antagonists/pharmacokinetics , Aged , Antihypertensive Agents/chemistry , Antihypertensive Agents/pharmacokinetics , Carbazoles/chemistry , Carbazoles/pharmacokinetics , Carvedilol , Chromatography, High Pressure Liquid , Female , Humans , Propanolamines/chemistry , Propanolamines/pharmacokinetics , Stereoisomerism
SELECTION OF CITATIONS
SEARCH DETAIL
...